[English] 日本語
Yorodumi
- PDB-7uj8: Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex wi... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 7uj8
TitleEstrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with 4-Hydroxytamoxifen
ComponentsEstrogen receptor
KeywordsTRANSCRIPTION / Alpha helical bundle / hormone receptor / breast cancer / tamoxifen / activating mutation
Function / homology
Function and homology information


regulation of epithelial cell apoptotic process / antral ovarian follicle growth / G protein-coupled estrogen receptor activity / regulation of branching involved in prostate gland morphogenesis / RUNX1 regulates transcription of genes involved in WNT signaling / RUNX1 regulates estrogen receptor mediated transcription / regulation of toll-like receptor signaling pathway / prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis / nuclear estrogen receptor activity / epithelial cell proliferation involved in mammary gland duct elongation ...regulation of epithelial cell apoptotic process / antral ovarian follicle growth / G protein-coupled estrogen receptor activity / regulation of branching involved in prostate gland morphogenesis / RUNX1 regulates transcription of genes involved in WNT signaling / RUNX1 regulates estrogen receptor mediated transcription / regulation of toll-like receptor signaling pathway / prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis / nuclear estrogen receptor activity / epithelial cell proliferation involved in mammary gland duct elongation / epithelial cell development / prostate epithelial cord elongation / negative regulation of smooth muscle cell apoptotic process / mammary gland branching involved in pregnancy / uterus development / vagina development / TFIIB-class transcription factor binding / androgen metabolic process / steroid hormone receptor signaling pathway / mammary gland alveolus development / estrogen receptor signaling pathway / cellular response to estrogen stimulus / estrogen response element binding / : / nuclear receptor-mediated steroid hormone signaling pathway / negative regulation of canonical NF-kappaB signal transduction / Nuclear signaling by ERBB4 / RNA polymerase II preinitiation complex assembly / protein localization to chromatin / 14-3-3 protein binding / TBP-class protein binding / nitric-oxide synthase regulator activity / steroid binding / TFAP2 (AP-2) family regulates transcription of growth factors and their receptors / ESR-mediated signaling / transcription corepressor binding / negative regulation of miRNA transcription / positive regulation of nitric-oxide synthase activity / cellular response to estradiol stimulus / transcription coregulator binding / stem cell differentiation / nuclear estrogen receptor binding / SUMOylation of intracellular receptors / euchromatin / negative regulation of DNA-binding transcription factor activity / beta-catenin binding / transcription coactivator binding / positive regulation of DNA-binding transcription factor activity / Nuclear Receptor transcription pathway / response to estrogen / Regulation of RUNX2 expression and activity / Constitutive Signaling by Aberrant PI3K in Cancer / nuclear receptor activity / male gonad development / positive regulation of nitric oxide biosynthetic process / sequence-specific double-stranded DNA binding / positive regulation of fibroblast proliferation / Ovarian tumor domain proteases / PIP3 activates AKT signaling / response to estradiol / phospholipase C-activating G protein-coupled receptor signaling pathway / positive regulation of cytosolic calcium ion concentration / ATPase binding / fibroblast proliferation / regulation of inflammatory response / PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling / DNA-binding transcription activator activity, RNA polymerase II-specific / Estrogen-dependent gene expression / transcription regulator complex / Extra-nuclear estrogen signaling / calmodulin binding / DNA-binding transcription factor activity, RNA polymerase II-specific / chromatin remodeling / RNA polymerase II cis-regulatory region sequence-specific DNA binding / DNA-binding transcription factor activity / negative regulation of gene expression / chromatin binding / regulation of DNA-templated transcription / chromatin / regulation of transcription by RNA polymerase II / protein kinase binding / positive regulation of DNA-templated transcription / Golgi apparatus / enzyme binding / negative regulation of transcription by RNA polymerase II / signal transduction / positive regulation of transcription by RNA polymerase II / protein-containing complex / zinc ion binding / nucleoplasm / identical protein binding / membrane / nucleus / plasma membrane / cytoplasm / cytosol
Similarity search - Function
Estrogen receptor / Oestrogen-type nuclear receptor final C-terminal domain / : / Oestrogen receptor / Oestrogen-type nuclear receptor final C-terminal / Estrogen receptor/oestrogen-related receptor / Nuclear hormone receptor / Nuclear hormones receptors DNA-binding region signature. / Zinc finger, nuclear hormone receptor-type / Zinc finger, C4 type (two domains) ...Estrogen receptor / Oestrogen-type nuclear receptor final C-terminal domain / : / Oestrogen receptor / Oestrogen-type nuclear receptor final C-terminal / Estrogen receptor/oestrogen-related receptor / Nuclear hormone receptor / Nuclear hormones receptors DNA-binding region signature. / Zinc finger, nuclear hormone receptor-type / Zinc finger, C4 type (two domains) / Nuclear hormone receptors DNA-binding domain profile. / c4 zinc finger in nuclear hormone receptors / Nuclear hormone receptor, ligand-binding domain / Nuclear hormone receptor-like domain superfamily / Ligand-binding domain of nuclear hormone receptor / Nuclear receptor (NR) ligand-binding (LBD) domain profile. / Ligand binding domain of hormone receptors / Zinc finger, NHR/GATA-type
Similarity search - Domain/homology
4-HYDROXYTAMOXIFEN / Estrogen receptor
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.385 Å
AuthorsHosfield, D.J. / Greene, G.L. / Fanning, S.W.
Funding support1items
OrganizationGrant numberCountry
Not funded
CitationJournal: Elife / Year: 2022
Title: Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells.
Authors: Hosfield, D.J. / Weber, S. / Li, N.S. / Suavage, M. / Joiner, C.F. / Hancock, G.R. / Sullivan, E.A. / Ndukwe, E. / Han, R. / Cush, S. / Laine, M. / Mader, S.C. / Greene, G.L. / Fanning, S.W.
History
DepositionMar 30, 2022Deposition site: RCSB / Processing site: RCSB
Revision 1.0Jun 15, 2022Provider: repository / Type: Initial release
Revision 1.1Oct 18, 2023Group: Data collection / Refinement description
Category: chem_comp_atom / chem_comp_bond / pdbx_initial_refinement_model

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
B: Estrogen receptor
A: Estrogen receptor
hetero molecules


Theoretical massNumber of molelcules
Total (without water)60,8434
Polymers60,0682
Non-polymers7752
Water1,04558
1


  • Idetical with deposited unit
  • defined by author&software
  • Evidence: homology
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area4390 Å2
ΔGint-6 kcal/mol
Surface area18700 Å2
MethodPISA
Unit cell
Length a, b, c (Å)104.201, 55.067, 97.479
Angle α, β, γ (deg.)90.000, 113.480, 90.000
Int Tables number5
Space group name H-MC121

-
Components

#1: Protein Estrogen receptor / ER / ER-alpha / Estradiol receptor / Nuclear receptor subfamily 3 group A member 1


Mass: 30034.029 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: ESR1, ESR, NR3A1 / Production host: Escherichia coli (E. coli) / References: UniProt: P03372
#2: Chemical ChemComp-OHT / 4-HYDROXYTAMOXIFEN


Mass: 387.514 Da / Num. of mol.: 2 / Source method: obtained synthetically / Formula: C26H29NO2 / Feature type: SUBJECT OF INVESTIGATION
#3: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 58 / Source method: isolated from a natural source / Formula: H2O
Has ligand of interestY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.14 Å3/Da / Density % sol: 42.39 %
Crystal growTemperature: 298 K / Method: vapor diffusion, hanging drop / pH: 6.5 / Details: PEG 3,350, MgCl2, Tris

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: APS / Beamline: 19-BM / Wavelength: 0.987 Å
DetectorType: MAR CCD 165 mm / Detector: CCD / Date: Apr 10, 2019
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.987 Å / Relative weight: 1
ReflectionResolution: 2.38→50 Å / Num. obs: 19734 / % possible obs: 96.7 % / Redundancy: 3.1 % / CC1/2: 0.912 / Net I/σ(I): 2.83
Reflection shellResolution: 2.38→2.44 Å / Num. unique obs: 977 / CC1/2: 0.751

-
Processing

Software
NameVersionClassification
PHENIX1.9_1692refinement
PDB_EXTRACT3.27data extraction
HKL-3000data reduction
HKL-3000data scaling
PHENIXphasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 5UFX

5ufx


Resolution: 2.385→38.997 Å / SU ML: 0.31 / Cross valid method: THROUGHOUT / σ(F): 1.35 / Phase error: 29.03 / Stereochemistry target values: ML
RfactorNum. reflection% reflection
Rfree0.2714 1802 10.03 %
Rwork0.2423 16169 -
obs0.2453 17971 87.94 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL
Displacement parametersBiso max: 114.41 Å2 / Biso mean: 47.5385 Å2 / Biso min: 13.64 Å2
Refinement stepCycle: final / Resolution: 2.385→38.997 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms3313 0 58 58 3429
Biso mean--37.81 39.56 -
Num. residues----427
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.0063430
X-RAY DIFFRACTIONf_angle_d0.6944635
X-RAY DIFFRACTIONf_chiral_restr0.038554
X-RAY DIFFRACTIONf_plane_restr0.003569
X-RAY DIFFRACTIONf_dihedral_angle_d13.8061232
LS refinement shell

Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0

Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection Rwork% reflection obs (%)
2.3853-2.44980.2986760.298667048
2.4498-2.52190.34121000.289784961
2.5219-2.60330.32861300.2998111680
2.6033-2.69630.3211350.2908128491
2.6963-2.80420.33621530.2829136096
2.8042-2.93180.28231460.2786136498
2.9318-3.08630.33511480.2676138798
3.0863-3.27960.28561640.2583137798
3.2796-3.53270.27571470.2523137398
3.5327-3.88790.27011400.2421117483
3.8879-4.44980.21931470.2032139597
4.4498-5.60360.22711540.2137140198
5.6036-38.9970.2611620.2134141996
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL11 (°2)L12 (°2)L13 (°2)L22 (°2)L23 (°2)L33 (°2)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T11 (Å2)T12 (Å2)T13 (Å2)T22 (Å2)T23 (Å2)T33 (Å2)Origin x (Å)Origin y (Å)Origin z (Å)
18.8612.73550.75741.0634-0.50525.3338-0.3099-0.50633.09220.59570.20220.4473-1.4053-0.23820.12251.0910.20480.10360.3493-0.11030.82462.3448.61426.345
26.29616.7177-3.16622.1189-3.55643.9198-0.4651-0.02150.1826-0.6050.43510.18750.0462-0.5253-0.03860.33790.0908-0.03580.3249-0.00990.4141-14.778-11.18821.661
36.89823.86650.66663.6184-1.49122.83840.16030.3203-0.2505-0.2034-0.2061-0.15450.0399-0.29920.0310.22240.08940.04220.3361-0.07810.2949-9.789-9.80415.43
44.58762.6495-0.16813.0219-2.06952.0088-0.25570.12551.2577-0.0587-0.15090.8727-1.58120.57780.37190.5691-0.0192-0.06060.32190.10910.43094.7724.9412.076
56.07921.4016-1.17874.8282-2.51036.378-0.44230.05740.02910.03670.144-0.01390.19230.36960.25320.23190.0664-0.00970.2259-0.06060.25740.322-7.9915.814
66.9950.9652.99032.62890.51045.5460.1566-1.1083-0.33250.7540.02340.71630.575-0.3397-0.14730.40.06240.13980.71070.30240.5845-10.796-16.7930.234
78.61594.00693.83877.2859-2.22546.8284-0.8237-0.383-2.7769-0.84870.774-1.19680.5798-0.77980.12310.6531-0.03120.21010.6340.04481.35-9.975-28.122.82
85.08153.66082.490210.15784.11928.99950.083-1.1203-1.05360.5707-0.3081-0.41330.7858-0.23280.29990.38430.11110.09430.51590.21290.5274-0.476-19.1830.068
96.56730.91121.57743.65210.40333.675-0.3085-0.69070.93120.20560.2258-0.2531-1.1174-0.38770.04970.44750.1432-0.05060.2961-0.14190.51638.214-0.19727.345
107.58111.88192.99216.28943.15836.6312-0.0514-0.46-0.29490.17410.15750.06540.0630.2295-0.09420.22860.11380.04720.316-0.01650.26898.137-13.26325.345
112.507-1.89231.13812.0479-7.44936.4634-0.18350.2873-0.0746-2.36140.29221.60020.9324-1.0159-0.17180.7272-0.0793-0.12270.9176-0.09490.4526-5.677-8.5624.758
126.30951.0019-2.44196.1811.35278.3892-0.5005-1.43790.66191.27290.4541-0.56630.67140.60380.08030.45690.1316-0.12530.5038-0.040.29230.806-15.93437.375
135.3221-1.1006-0.05266.55441.77293.53630.2085-0.1067-0.9095-0.1924-0.15920.24870.48080.3145-0.04980.27630.0992-0.04260.2768-0.01890.321525.11-27.80121.721
148.0006-2.7514-1.63556.70132.4426.02940.40861.83520.4391-1.0938-0.21820.2859-0.42720.3232-0.14590.55250.13090.05930.6180.11060.360126.555-19.4245.199
158.82085.63827.91239.52949.57422.3991-0.24710.83720.6743-1.437-0.04220.2188-1.29250.06280.34340.51350.02560.0180.61650.14230.337322.363-11.4711.06
165.38571.2891-0.7857.88390.58075.4431-0.1308-0.52420.47620.49750.04530.2391-0.3009-0.18670.08660.26260.115-0.0750.3059-0.02390.243822.314-12.34130.835
175.62912.87443.58379.69755.60617.6436-0.1032-0.15760.2191-0.482-0.54050.8096-0.4078-0.49090.60660.19830.11020.03270.26340.01730.321416.001-12.72920.107
182.23971.4150.00723.95762.90212.7454-0.42020.0991-2.4731-0.0256-0.40.1732.6333-0.38510.36431.38430.19640.52310.260.0431.651419.804-37.65826.114
Refinement TLS group
IDRefine-IDRefine TLS-IDSelection detailsAuth asym-IDAuth seq-ID
1X-RAY DIFFRACTION1( CHAIN A AND RESID 309:321 )A309 - 321
2X-RAY DIFFRACTION2( CHAIN A AND RESID 322:334 )A322 - 334
3X-RAY DIFFRACTION3( CHAIN A AND RESID 342:363 )A342 - 363
4X-RAY DIFFRACTION4( CHAIN A AND RESID 364:371 )A364 - 371
5X-RAY DIFFRACTION5( CHAIN A AND RESID 372:394 )A372 - 394
6X-RAY DIFFRACTION6( CHAIN A AND RESID 395:412 )A395 - 412
7X-RAY DIFFRACTION7( CHAIN A AND RESID 413:420 )A413 - 420
8X-RAY DIFFRACTION8( CHAIN A AND RESID 421:437 )A421 - 437
9X-RAY DIFFRACTION9( CHAIN A AND RESID 438:496 )A438 - 496
10X-RAY DIFFRACTION10( CHAIN A AND RESID 497:526 )A497 - 526
11X-RAY DIFFRACTION11( CHAIN A AND RESID 527:545 )A527 - 545
12X-RAY DIFFRACTION12( CHAIN B AND RESID 309:321 )B309 - 321
13X-RAY DIFFRACTION13( CHAIN B AND RESID 322:394 )B322 - 394
14X-RAY DIFFRACTION14( CHAIN B AND RESID 395:423 )B395 - 423
15X-RAY DIFFRACTION15( CHAIN B AND RESID 424:437 )B424 - 437
16X-RAY DIFFRACTION16( CHAIN B AND RESID 438:496 )B438 - 496
17X-RAY DIFFRACTION17( CHAIN B AND RESID 497:526 )B497 - 526
18X-RAY DIFFRACTION18( CHAIN B AND RESID 527:545 )B527 - 545

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbjlvh1.pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more